A Spectroscopic Approach to Investigate the Molecular Interactions between the Newly Approved Irreversible ErbB blocker "Afatinib" and Bovine Serum Albumin-Reference-Cited by-同舟云学术

A Spectroscopic Approach to Investigate the Molecular Interactions between the Newly Approved Irreversible ErbB blocker "Afatinib" and Bovine Serum Albumin

Published:2016-01-11 Issue:1 Volume:11 Page:e0146297
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Alanazi Amer M.,Abdelhameed Ali Saber

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Afatinib pharmacokinetics and metabolism after oral administration to healthy male volunteers;P Stopfer;Cancer Chemother Pharmacol,2012

2. Center for drug evaluation and Research,2013

3. Molecular aspects of ligand binding to serum albumin;U Kragh-Hansen;Pharmacol Rev,1981

4. Atomic structure and chemistry of human serum albumin;XM He;Nature,1992

5. Crystallographic analysis reveals modes of binding of medium and long chain fatty acids to human serum albumin;AA Bhattacharya;Journal of Molecular Biology,2000

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring dimethoxy naphthalenyl methoxyphenyl quinazolinyl amine as a PDE10A inhibitor: In-silico studies, synthesis and binding interactions with serum albumin;Journal of Molecular Liquids;2024-10

2. Biophysical studies of human serum albumin with cocaine and cocaethylene: Understanding the drug-protein interaction in simulated physiological conditions;Journal of Molecular Liquids;2024-09

3. AFATINIB-A COMPREHENSIVE REVIEW OF ANALYTICAL METHODS DEVELOPED IN PHARMACEUTICALS AND BIOLOGICAL MATRICES;International Journal of Applied Pharmaceutics;2024-07-07

4. Phase separation, aggregation, and complexation of triton-X100 and bovine serum albumin mixture: A combined cloud point and UV–visible spectroscopic approaches;International Journal of Biological Macromolecules;2024-06

5. Investigation of the Interaction of Monoamine Oxidase (MAO) Inhibitor Biscoumarins with Hemoglobin and Albumin Using Multi-Spectroscopic Techniques and Molecular Docking;Analytical Letters;2024-04-21